INMD - InMode Ltd.


13.45
-0.110   -0.818%

Share volume: 352,370
Last Updated: 03-05-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$13.56
-0.11
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
67%
Profitability 75%
Dept financing 8%
Liquidity 63%
Performance 75%
Company vs Stock growth
vs
Performance
5 Days
-0.59%
1 Month
-8.50%
3 Months
-5.96%
6 Months
-9.48%
1 Year
-29.60%
2 Year
-40.89%
Key data
Stock price
$13.45
P/E Ratio 
0.00
DAY RANGE
$13.42 - $13.65
EPS 
$1.24
52 WEEK RANGE
$13.14 - $19.78
52 WEEK CHANGE
-$29.78
MARKET CAP 
1.403 B
YIELD 
N/A
SHARES OUTSTANDING 
83.982 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-31-2025
BETA 
1.60
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$986,760
AVERAGE 30 VOLUME 
$1,234,235
Company detail
CEO: Moshe Mizrahy
Region: US
Website: inmodemd.com
Employees: 480
IPO year: 2019
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company was formerly known as Invasix Ltd. and changed its name to In Mode Ltd. in November 2017.

Recent news